Senate Bill 3 — Apr. 12, 2016 by Senate, 42-7, and Apr. 13 by House, 149-46
Signed into law by Gov. Tom Wolf (D) on Apr. 17, 2016

Effective: 30 days after passage

Approved Conditions: Cancer, HIV/AIDS, ALS, Parkinson’s, multiple sclerosis, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, inflammatory bowel disease, neuropathies, Huntington’s disease, Crohn’s disease, PTSD, intractable seizures, glaucoma, sickle cell anemia, severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain in which conventional therapeutic intervention and opiate therapy is contraindicated or ineffective, autism.

Possession/Cultivation: 30-day supply; According to SB 3, “Medical marijuana may only be dispensed to a patient or caregiver in the following forms: (i) pill; (ii) oil; (iii) topical forms, including gel, creams or ointments; (iv) a form medically appropriate for administration by vaporization or nebulization, excluding dry leaf or plant form… (v) tincture; or (vi) liquid. Unless otherwise provided in regulations adopted by the department under section 1202, medical marijuana may not be dispensed to a patient or a caregiver in dry leaf or plant form.”

Smoking is not a method approved by the bill.

Update:
On June 24, 2016 , Pennsylvania Secretary of Health Karen Murphy announced new guidelines for a Safe Harbor provision: “In July [2016], parents, legal guardians, caregivers, and spouses will be able to apply to the department for a Safe Harbor Letter that will allow them to administer medical marijuana obtained from outside of Pennsylvania to minors in their care. Once approved, the letter should be carried whenever medical marijuana is being transported outside of an individual’s home.”